Value in Health

Estimates of Costs of Hospital Stay for Variceal and Nonvariceal Upper Gastrointestinal Bleeding in the United States
pp. 1-3(3)
Authors: Viviane, Adam; Alan, Barkun N.

Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice
pp. 4-12(9)
Authors: Cordony, Anna; Le Reun, Corinne; Smala, Antje; Symanowski, James T.; Watkins, Jessamy

Cost-of-Illness Studies in the United States: A Systematic Review of Methodologies Used for Direct Cost
pp. 13-21(9)
Authors: Clabaugh, Gerd; Ward, Marcia M.

Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus
pp. 22-33(12)
Authors: Minshall, Michael E.; Oglesby, Alan K.; Wintle, Matthew E.; Valentine, William J.; Roze, Stéphane; Palmer, Andrew J.

The Impact of Atypical Antipsychotic Medications on the Use of Health Care by Patients with Schizophrenia
pp. 34-43(10)
Authors: Chen, Lei; McCombs, Jeffrey S.; Park, Jinhee

Medication Compliance and Persistence: Terminology and Definitions
pp. 44-47(4)
Authors: Cramer, Joyce A.; Roy, Anuja; Burrell, Anita; Fairchild, Carol J.; Fuldeore, Mahesh J.; Ollendorf, Daniel A.; Wong, Peter K.

Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program
pp. 48-56(9)
Authors: Ahn, Jeonghoon; McCombs, Jeffrey S.; Jung, Changun; Croudace, Tim J.; McDonnell, David; Ascher-Svanum, Haya; Edgell, Eric T.; Shi, Lizheng

Does Epoetin Alfa Improve Health-Related Quality of Life in Chronically Ill Patients with Anemia? Summary of Trials of Cancer, HIV/AIDS, and Chronic Kidney Disease
pp. 57-75(19)
Authors: Kimel, Miriam; Leidy, Nancy K.; Mannix, Sally; Dixon, Julia

Health State Utilities: A Framework for Studying the Gap Between the Imagined and the Real
pp. 76-87(12)
Authors: Stiggelbout, Anne M.; de Vogel-Voogt, Elsbeth

The Impact of Medical Technology on Health: A Longitudinal Analysis of Ischemic Heart Disease
pp. 88-96(9)
Authors: López-Valcárcel, Beatriz G.; Pinilla, Jaime

ARE N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience
pp. 97-109(13)
Authors: Scuffham, Paul A.; Yelland, Michael J.; Nikles, Jane; Pietrzak, Eva; Wilkinson, David

Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population
pp. 110-118(9)
Authors: Bae, Seung Jin; Paltiel, A. David; Fuhlbrigge, Anne L.; Weiss, Scott T.; Kuntz, Karen M.

Private Demand for Cholera Vaccines in Hue, Vietnam
pp. 119-128(10)
Authors: Kim, Dohyeong; Canh, Do G.; Poulos, Christine; Thoa, Le T. K.; Cook, Joe; Hoa, Nguyen T.; Nyamete, Andrew; Thuy, Dang T. D.; Deen, Jacqueline; Clemens, John; Thiem, Vu D.; Anh, Dang D.; Whittington, Dale

Better Pharmaceutical Price Comparison Studies Are Needed for Meaningful Evaluation of Price-Control Policies
pp. 129-130(2)